ACTR-27. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE RECURRENT GLIOBLASTOMA

Glioblastoma (GBM) is the most common and aggressive primary brain cancer. Current standard-of-care includes surgery followed by concurrent therapy with radiation and temozolomide (TMZ) and maintenance TMZ. Almost all GBM patients experience recurrent/progressive disease, and median survival after r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: O’Brien, Barbara, de Groot, John, Kamiya-Matsuoka, Carlos, Weathers, Shiao-Pei, Bacha, Jeffrey, Brown, Dennis, Steino, Anne, Langlands, John, Schwartz, Richard, Kanekal, Sarath, Lopez, Lorena, Penas-Prado, Marta
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216173/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados